Patents by Inventor Fong Wang

Fong Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of Talazoparib and Enzalutamide in the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Publication number: 20260108513
    Abstract: This invention relates to talazoparib, or a pharmaceutically acceptable salt thereof, in combination with enzalutamide, or a pharmaceutically acceptable salt thereof, for the treatment of metastatic castration-resistant prostate cancer and methods of increasing survival thereof.
    Type: Application
    Filed: September 29, 2023
    Publication date: April 23, 2026
    Inventors: Akos Gabor Czibere, Dana Ann Kennedy, Maria Teresa Koehler, Sandra Jean Meech, Fong Wang
  • PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
    Publication number: 20070293570
    Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.
    Type: Application
    Filed: February 15, 2007
    Publication date: December 20, 2007
    Applicant: WARNER-LAMBERT COMPANY
    Inventors: David Dooley, Charles Taylor, Jr., Andrew Thorpe, Fong Wang, David Wustrow
  • PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
    Publication number: 20070276039
    Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.
    Type: Application
    Filed: March 19, 2007
    Publication date: November 29, 2007
    Applicant: WARNER-LAMBERT COMPANY LLC
    Inventors: David Dooley, Charles Taylor, Jr., Andrew Thorpe, Fong Wang, David Wustrow
  • Alpha2delta ligands for the treatment of fibromyalgia and other disorders
    Publication number: 20070238749
    Abstract: The invention relates to a method of treating fibromyalgia and other disorders in a mammal by administering a compound compound of Formula I R1 is straight or branched unsubstituted alkyl of from 1 to 5 carbon atoms, unsubstituted phenyl, or unsubstituted cycloalkyl of from 3 to 6 carbon atoms; R2 is hydrogen or methyl; and R3 is hydrogen, methyl, or carboxyl, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 18, 2007
    Publication date: October 11, 2007
    Inventors: Charles Taylor, Andrew Thorpe, Fong Wang, David Wustrow
  • PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
    Publication number: 20070213401
    Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.
    Type: Application
    Filed: March 19, 2007
    Publication date: September 13, 2007
    Applicant: WARNER-LAMBERT COMPANY LLC
    Inventors: David Dooley, Charles Taylor, Jr., Andrew Thorpe, Fong Wang, David Wustrow
  • PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
    Publication number: 20070161706
    Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.
    Type: Application
    Filed: March 19, 2007
    Publication date: July 12, 2007
    Applicant: WARNER-LAMBERT COMPANY LLC
    Inventors: David Dooley, Charles Taylor, Jr., Andrew Thorpe, Fong Wang, David Wustrow
  • PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
    Publication number: 20070161707
    Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.
    Type: Application
    Filed: March 19, 2007
    Publication date: July 12, 2007
    Applicant: WARNER-LAMBERT COMPANY LLC
    Inventors: David Dooley, Charles Taylor, Andrew Thorpe, Fong Wang, David Wustrow
  • Methods for using amino acids with affinity for the alpha2delta-protein
    Publication number: 20060247282
    Abstract: This invention relates to certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
    Type: Application
    Filed: June 30, 2006
    Publication date: November 2, 2006
    Inventors: Candace Bramson, George Haig, Denis Schrier, Fong Wang
  • Methods for using amino acids with affinity for the ?2?-protein
    Patent number: 7112610
    Abstract: This invention relates to certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
    Type: Grant
    Filed: September 24, 2004
    Date of Patent: September 26, 2006
    Assignee: Warner-Lambert Company LLC
    Inventors: Candice Bramson, George M. Haig, Denis J. Schrier, Fong Wang
  • Methods for using amino acids with affinity for the alpha2delta-protein
    Publication number: 20050124669
    Abstract: This invention relates to certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
    Type: Application
    Filed: September 24, 2004
    Publication date: June 9, 2005
    Inventors: Candace Bramson, George Haig, Denis Schrier, Fong Wang
  • Alpha2delta ligands for the treatment of fibromyalgia and other disorders
    Publication number: 20040138305
    Abstract: The invention relates to a method of treating fibromyalgia and other disorders in a mammal by administering a compound compound of Formula I 1
    Type: Application
    Filed: December 9, 2003
    Publication date: July 15, 2004
    Inventors: Charles Price Taylor, Andrew John Thorpe, Fong Wang, David Juergen Wustrow
  • Pharmaceutical uses for alpha2delta ligands
    Publication number: 20040132636
    Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula 1
    Type: Application
    Filed: December 9, 2003
    Publication date: July 8, 2004
    Inventors: David James Dooley, Charles Price Taylor, Andrew John Thorpe, Fong Wang, David Juergen Wustrow